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ORIGINAL ARTICLE
Reasons For Screening And Methods Of Diagnosing Type
II Diabetes Mellitus
Lam Tai Pong*, MBBS, FRACGP
Lecturer
General Practice Unit
Department of Medicine
The University of Hong Kong
Summary
The aim of this study was to assess the reasons
for screening and the methods of diagnosing Type II
diabetic patients. It was a retrospective analysis of
patients attending the Ap Lei Chan Clinic of the
General Practice Unit of the University of Hong
Kong. Of a total patient population of 3,400, 47
new cases of Type II diabetes mellitus were
diagnosed between September 1992 and September
1993. Three quarters of these newty diagnosed
diabetic patients were asymptomatic at the time of
diagnosis. Only 4% presented with the classical
symptoms of polyuria and/or polydipsia. About one
third required oral glucose tolerance test to confirm
the diagnosis. Screening of asymptomatic patients is
important to identify many of the undiagnosed Type
II diabetic patients. An oral glucose tolerance test
(OGTT) should be performed in those whose fasting
blood sugar was elevated but not diagnostic of
diabetes mellitus.
KeyWords: Diabetes mell i tus , Chinese,
screening, body mass index, oral
glucose tolerance test.
Introduction
Type II (non-insulin dependent) diabetes
mellitus is a common condition worldwide,
particularly in the developed world. In the United
States, it is estimated that for every known Type
II diabetic patient, there is another undiagnosed
Type II patient.1 How can we identify these
undiagnosed Type II patients in a most effective
way?
There is a lot of literature on whether
asymptomatic patients should be screened for
diabetes and what is the best method.2'3
However, they are mainly based on Caucasian
patients in countries with well developed health
care systems.4"5 We now recognize that there are
differences in characteristics among various ethnic
groups including age at diagnosis, methods of
treatment, prevalence of complications and body
mass index (BMI).6 The objective of this study
was to analyze the reasons for screening and the
methods of diagnosing Type II diabetes mellitus in
Hong Kong Chinese patients.
Subjects and Methods
The study was conducted at Ap Lei Chau
Clinic which is the teaching practice of the
General Practice Unit of the University of Hong
Kong. The clinic began operation in early
September 1992 and was accepting all self-referred
cases. By September 1, 1993, there were
approximately 3,400 patients registered with the
practice.
Patients with the diagnosis of Type II
diabetes mellitus were listed from the computer
records on September 1, 1993. All the files were
then reviewed. Patients who had their diabetes
first diagnosed during our first twelve months of
"Address for correspondence: Dr. Lam Tai Pong, General Practice Unit, The University of Hong Kong, 3/F, Ap Lei chau Clinic, 161
Main Street, Ap Lei Chau, Hong Kong.
149
Screening and Diagnosing Type II Diabetes Mellitus
service at Ap Lei Chau were categorized as newly
diagnosed. The reasons for screening their
diabetes by the doctors and their presenting
symptoms at diagnosis were entered onto a
prescribed form. The methods of confirming the
diagnosis were also noted. The data was then
analyzed using the SPSS.PC programme.
All the subjects in whom plasma glucose
levels were abnormally elevated but not diagnostic
of diabetes mellitus (defined as between 6.1 and 8
mmol/l for fasting specimen and between 8 and
11.1 mmol/l for random specimen) had 75gm
glucose OGTT performed at our clinic. This was
undertaken in the morning after overnight fasting.
Patients were asked to continue their usual diet.
A diagnosis of diabetes mellitus was made if
the plasma glucose at 2-hour post 15gm glucose
was greater than or equal to 11.1 mmol/l.
Plasma glucose was measured with the
RefLab™ System Pack Liquid Reagent on an
Abbott Spectrum Analyzer. The assay employed
the hexokinase-glucose-6-phosphate dehydro-
genase double enzyme system.
Results
The mean values of BMI of these diabetic
patients are shown in Table 2 and they were
significantly higher when compared to over-30
non-diabetic patients.
Table 1: Age and Sex Distribution of Newly
Diagnosed Type II Diabetic Patients
Men
Mean Age (S.D.) 58.3 (10.9)
n= 14
Women
63.3 (11.3)
n = 33
Table 2: Mean BMI of Newly Diagnosed Type n
Diabetic Patients and Non-diabetic
Patients
Men Women
Mean
BMI
(S.D.)
Diabetic*
28.1
(5.7)
n = 14
Non-
diabetic*
24.5
(4.0)
n = 387
Diabetic1
27.0
(3.9)
n = 33
Non-
diabetic11
25.0
(4.3)
n - 1231
' p < 0.02 (student's t-test)
k
 p < 0.01 (student's t-test)
The prevalence of Type II diabetes mellitus in
this patient population was reported in an earlier
study.7 Forty-seven patients had their Type II
diabetes first diagnosed between September 1992
and September 1993.
Data on the age, sex, BMI, symptoms at
diagnosis, glycosuria, fasting blood sugar (FBS),
random blood sugar level (BSL), BSL at 2 hours
after 15gm glucose, reasons for suspecting the
diagnosis and methods of diagnosis is presented in
Appendix 1.
The age and sex distribution of the patients is
shown in Table 1. Women outnumbered men by
two and half times. However, there are generally
twice as many women attending our clinic as men.
Table 3 shows the distribution of symptoms at
diagnosis. "Asymptomatic" patients were those
who had the screening test done purely as a result
of the doctors' decision to screen, no diabetes
related symptoms were recorded in the medical
records. The patients might or might not have
had specific questions asked in relation to
diabetes. Three quarters of the patients did not
have any symptoms at the time of diagnosis.
Twelve percent (4/33) of the female patients had
vaginal symptoms. Only 4% (2/47) of the patients
presented with the classical symptoms of polyuria
and/or polydipsia. Just over 10% (5/47) were
diagnosed separately at various clinics or hospitals
and came to us for further long term
management. One patient had a history of
gestational diabetes mellitus.
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Table 3: Distribution of Symptoms at Diagnosis
Number
Symptoms at Diagnosis of Patients %
Asymptomatic 35
Vaginal symptoms 4
Polyuria/polydipsia 2
Diagnosed at other clinics/hospitals 5
Past history of Gestational DM 1
74.5
8.5
4.3
10.6
2.1
Total 47 100.0
Table 4 shows the distribution of reasons for
suspecting diabetes. The reasons might be related
to symptoms, past medical history or screening
tests.
Thirty of these 47 patients were on treatment
for hypertension. Our hypertensive patients were
regularly screened for diabetes by blood or urine
tests (at first consultation with known
hypertension, at diagnosis of hypertension and at
twelve-month intervals).
Only 13% (6/47) had symptoms related to
diabetes. Over half of the patients (26/47) were
suspected to have diabetes as a result of elevated
FBS levels (defined as between 6.1 and 8 mmol/f).
About one fifth (10/47) of the patients had
positive screening glycosuria while 4% (2/47) had
elevated random BSL.
Table 4: Distribution of Reasons for Suspecting
Type II Diabetes Mellitus
Reason for Suspecting Type II
Diabetes Mellitus
Raised screening FBS
Positive screening glycosuria
Symptoms e.g. polyuria/polydipsia,
vaginal discharge
Raised random BSL
Past history of Gestational DM
Diagnosed at other clinics/hospitals
Number
of Patients
26
10
6
2
1
2
%
55.3
21.3
12.8
4.3
2.1
4.3
Table 5 shows the distribution of methods of
diagnosis. WHO criteria for diagnosis were
adopted for this study.5 Nearly half (22/47) of the
patients had the diagnosis of diabetes confirmed
because of elevated FBS levels. About one third
(17/47) required OGTT by WHO standard.
Fifteen percent (7/47) had the diagnosis confirmed
by elevated random BSL.
Table 5: Distribution of Methods of Diagnosis
Type II Diabetes Mellitus
Confirmed by
Fasting BSL
OGTT
Random BSL
Unknown
Number
of Patients
22
17
7
1
%
46.8
36.2
14.9
2.1
Total 47 100.0
FBS = Fasting Blood Sugar; BSL = Blood Sugar Level.
Total 47 100.0
FBS = Fasting Blood Sugar;
BSL = Blood Sugar Level.
Discussion
Most of our patients did not complain of
symptoms at the time of diagnosis. It may be
that they were not asked about diabetic
symptoms. However, patients did not complain
of them either. We did not think it was
worthwhile analyzing the related symptoms after
the diagnosis had been made because patients
might tend to respond positively to leading
questions once the condition was confirmed.
Several patients e.g. case 6, 12, 16, 22, 34,
42 & 47 had very high FBS levels (ranged from
14.4 to 18.4 mmollt) or random BSL (ranged
from 15.3 to 18.9 mmol/l) and yet they did not
complain of any diabetic symptoms to their
doctors. This demonstrates that some patients
may remain asymptomatic despite grossly
elevated blood sugar levels.
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Twenty patients were screened for
glycosuria, the test was positive in only 17. In
fact, it is quite possible that many undiagnosed
diabetic patients may not show a positive result
for glycosuria on urine screening unless the urine
sample was taken after a reasonable sized meal.
It is still common practice in many countries for
urinalysis to be used to screen for diabetes
although not recommended in official guidelines
of the Colleges or National Associations.2 With
user-friendly reflectance glucometers readily
available at reasonable prices these days, there is
no reason to continue with the practice of using
urinalysis to screen for diabetes.
OGTT was required in about a third of
patients to confirm the diagnosis of diabetes.
All of these patients had FBS or random BSL
which were elevated but not within the
diagnostic range. The reluctance of elderly
Chinese to accept repeated venepunctures was
thought to be an obstacle to arrange OGTT by
a previous local study.9 However, we did not
find it to be a problem among our patients
despite the fact that 11 out of the 17 patients
who required OGTT were 60 or above. Fasting
blood specimens were also considered difficult to
obtain among elderly Chinese in the same
previous study. Again, we did not experience
any major difficulties ourselves. This is
evidenced by the fact that 26 of these 47
patients had fasting blood taken and 15 of these
26 patients were 60 or above. It is important to
explain to the patients the reasons for the blood
tests and ensure that they understand them.
It is also interesting to note the 2-hour post
75gm glucose BSL in some patients e.g. case 7,
23 & 39. Their FBS levels ranged from 6.3 to
7,1 mmolll and yet their 2-hour BSL were
between 16.8 to 19.1 mmolll. Furthermore, the
BMI of these patients were only 24.0 to 27.9.
Therefore, it is essential to perform OGTT on
patients with even slightly elevated FBS levels.
Our study is limited by the small number of
patients. It is also a retrospective analysis and
many patients did not have all the relevant tests
performed. The reasons for suspecting diabetes
might also be a reflection of the clinical behaviour
of the doctors in our clinic e.g. screening for
diabetes among hypertensive patients.
One patient (Case 9) had positive screening
for glycosuria. She apparently had diabetes
subsequently confirmed by blood tests in a
hospital. However, we were unable to obtain
results of those tests and she declined further
blood taking. There is a possibility that she may
not be a true diabetic.
Conclusion
Most Type II diabetic patients are
asymptomatic at the time of diagnosis.
Urinalysis is not an absolutely reliable method
for screening. Patients with a FBS which is
elevated but not diagnostic of diabetes should
have OGTT which may be the only method to
confirm the diagnosis.
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Appendix 1: Age, sex, BMI, related symptoms, glucose levels, reason for suspecting and method of
diagnosis
Case
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
Age
72
53
60
63
66
63
51
67
75
64
62
67
78
49
58
65
64
67
79
50
58
62
83
60
64
48
37
60
55
68
42
83
38
65
74
63
59
59
75
74
64
70
64
33
52
70
52
Sex
M
M
F
F
F
M
M
F
F
F
F
F
F
M
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
M
F
F
M
M
F
M
M
F
F
M
M
M
M
BMI
22.6
28.1
30.5
28.1
23.6
23.2
24.0
28.5
18.9
27.4
25.7
31.0
26.4
25.6
26.3
25.6
28.7
33.6
24.9
28.3
30.6
27.9
27.4
21.0
33.8
26.1
31.5
22.6
25.7
25.0
23.8
32.9
24.4
26.7
33.0
27.7
25.9
25.0
26.1
30.0
23.7
26.1
16.7
52.7
45.5
32.8
28.2
Symptoms Gtycosui
Asymptomatic
Asymptomatic
Pruritus Vulva +ve
Asymptomatic +ve
Asymptomatic +ve
Asymptomatic
Asymptomatic
Asymptomatic
Boil on Vulva +ve
Asymptomatic
Asymptomatic -t-ve
Asymptomatic +vc
Asymptomatic -ve
Asymptomatic -ve
Asymptomatic
Asymptomatic
Asymptomatic
Asymptomatic
Referred by Ophthalmologist
for Investigation
Asymptomatic
Asymptomatic
Asymptomatic +ve
Asymptomatic
Pruritus Vulva +ve
Asymptomatic
Asymptomatic
Vaginal Discharge
Asymptomatic
Polyuria and Polydipsia +ve
Diagnosed by GP
History of Gestational DM +ve
Asymptomatic +ve
Diagnosed by -ve
Family Planning Screening
Asymptomatic +ve
Asymptomatic
Asymptomatic
Asymptomatic
Diagnosed
by Hospital while on
treatment for tuberculosis
Asymptomatic
Diagnosed at Health Screening +ve
at Community Centre
Asymptomatic +ve
Asymptomatic +ve
Asymptomatic
Asymptomatic
Polyuria + Polydipsia +ve
Asymptomatic
Asymptomatic +ve
ia FBS
7.7
7.3
9.7
7.1
7.4
7.3
10.3
18.4
9.0
6.9
8.7
13.7
6.7
7.1
6.9
11.3
14.9
7.1
14.2
7.3
7.0
10.4
8.4
10.6
9.3
10.3
17.0
7.0
7.2
7.8
11.1
6.3
10.2
7.1
9.0
8.7
9.0
7.1
14.4
Random BSL 2 hours
BSL 75gm glucose
14.6
14.6
16.2
9.1 13.2
18.1
16.8
12.9
7.2 12.9
12.5
18.9
11.6
12.7
11.1
19.0
15.4
11.9
15.8
17.5
12.5
17.7
19.1
11.0
15.3
14.4
11.8
13.3
DM
Confirmed by
OGTT
OGTT
Random BSL
OGTT
Fasting BSL
Random BSL
OGTT
OGTT
OGTT
Fasting BSL
Fasting BSL
Fasting BSL
OGTT
Fasting BSL
Random BSL
Fasting BSL
OGTT
OGTT
OGTT
Fasting BSL
Fasting BSL
OGTT
Fasting BSL
OGTT
Fasting BSL
Fasting BSL
Fasting BSL
Fasting BSL
Random BSL
Fasting BSL
Fasting BSL
Fasting BSL
Fasting BSL
OGTT
OGTT
Fasting BSL
Fasting BSL
Fasting BSL
Random BSL
Random BSL
OGTT
OGTT
Fasting BSL
OGTT
Fasting BSL
Reason for
Suspecting DM
Raised Screening FBS
Raised Screening FBS
Vaginal Symptoms
Screening Glycosuria +ve
Screening Glycosuria +ve
Raised Random BSL
Raised Screening FBS
Raised Screening FBS
Raised Screening FBS
Screening Glycosuria +ve
Screening Glycosuria +ve
Raised Screening FBS
Raised Screening FBS
Raised Screening FBS
Raised Random BSL
Raised Screening FBS
Raised Screening FBS
Raised FBS
Raised Screening FBS
Raised Screening FBS
Raised Screening FBS
Raised Screening FBS
Vaginal Symptom
Raised Screening FBS
Raised Screening FBS
Vaginal Symptom and
History of Gestational DM
Raised Screening FBS
Polyuria + Polydipsia
History of Gestational DM
Screening Glycosuria +ve
Raised Screening FBS
Screening Glycosuria +ve
Raised Screening FBS
Raised Screening FBS
Raised Screening FBS
Raised Screening FBS
Raised Screening FBS
Screening Glycosuria +ve
Screening Glycosuria +ve
Screening Glycosuria +ve
Raised Screening FBS
Raised Screening FBS
Polyuria + Polydipsia
Raised Screening FBS
Screening Glycosuria +vc
FBS = Fasting Blood Sugar, BSL = Blood Sugar Level; OGTT = Oral Glucose Tolerance Test.
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